Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine immunological changes in postherpetic neuralgia
ChiCTR1900021277Phase 4Recruiting
- Sponsor
- Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in postherpetic neuralgia (PHN) (2 arms), sponsored by Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University. Primary endpoints: Protein chip and T-cell subset. Started Aug 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR1900021277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021277.